← SynDRA
ENZASTAURIN
SynDRA canonical compound SYN0002569 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PRKCB |
|---|
| Mechanism of action | PKC inhibitor |
|---|
All known targets
- PRKCB
- AKT1
- PRKCA
- PRKCD
- PRKCG
- GSK3B
- PIK3CG
Mechanisms of action (all sources)
- PKC inhibitor
- PRKCB INHIBITOR
- Protein kinase C beta inhibitor
- PRKCA INHIBITOR
- PRKCD INHIBITOR
- PRKCG INHIBITOR
- PRKCB MODULATOR
- AKT1 INHIBITOR
- PIK3CG INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- NUAK2
- RPS6KA4
- RPS6KA5
- RPS6KA6
- RPS6KB1
- PHKG1
- SLK
- JAK3
- KIT
- CLK4
- PDGFRB
- CLK2
- CLK1
- CILK1
- PAK3
- CDKL2
- FGFR1
- CDK7
- STK16
- STK17A
- CDK3
- CDK2
- STK26
- CDK16
- CDK15
- CDK14
- RPS6KA3
- RPS6KA2
- RPS6KA1
- GRK1
- PRKACB
- PRKCE
- PRKCH
- PRKACA
- PRKCQ
- PRKCZ
- PRKAA2
- FLT3
- PRKG1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP2C9
- CP3A7
- ESR1
- ESR2
- GCR
- GLI3
- KCNH2
- KPCA
- KPCD
- KPCG
- KSYK
- NR1H4
- NSD2
- PPARG
- TP53
Cross-references
Synonyms
- Enzastaurine
- Enzastaurina
- LY-317615
- DB-102
- DB102
- LY317615
- Kinenza
- LE-0014
- LY317615, Enzastaurin
- 3-(1-methyl-1H-indol-3-yl)-4-{1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione
- 3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione
- LY 317615
- enzastaurina
- UC96G28EQF
- ENZASTAURINE
- DTXCID3024029
- enzastaurinum
- RefChem:137067
- Enzastaurin (LY317615)
- MFCD11040980
- s1055
- Enzastaurin [INN]
- CAS-170364-57-5
- UNII-UC96G28EQF
- C32H29N5O2
- ENZASTAURIN [MI]
- Enzastaurin (USAN/INN)
- Enzastaurin [USAN:INN]
- Enzastaurin,LY317615
- ENZASTAURIN [USAN]
- Enzastaurin; LY317615
- ENZASTAURIN [WHO-DD]
- SCHEMBL678748
- Enzastaurin (LY317615)?
- GTPL5693
- orb1300907
- SCHEMBL29356867
- SCHEMBL29371538
Look up ENZASTAURIN in the interactive SynDRA portal →